These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22245188)

  • 21. Reduced power magnetic resonance spectroscopic imaging of the prostate at 4.0 Tesla.
    Near J; Romagnoli C; Bartha R
    Magn Reson Med; 2009 Feb; 61(2):273-81. PubMed ID: 19165876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level.
    Kumar V; Jagannathan NR; Kumar R; Das SC; Jindal L; Thulkar S; Gupta SD; Dwivedi SN; Roell S; Hemal AK; Gupta NP
    Magn Reson Imaging; 2006 Jun; 24(5):541-8. PubMed ID: 16735174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deformable image registration for the use of magnetic resonance spectroscopy in prostate treatment planning.
    Wu X; Dibiase SJ; Gullapalli R; Yu CX
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1577-83. PubMed ID: 15050339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two-dimensional spectroscopic imaging for pretreatment evaluation of prostate cancer: comparison with the step-section histology after radical prostatectomy.
    Weis J; Ahlström H; Hlavcak P; Häggman M; Ortiz-Nieto F; Bergman A
    Magn Reson Imaging; 2009 Jan; 27(1):87-93. PubMed ID: 18599244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of endorectal magnetic resonance spectroscopic imaging in two different Gleason scores in prostate cancer.
    Nagarajan R; Margolis D; McClure T; Raman S; Thomas MA
    Med Princ Pract; 2011; 20(5):444-8. PubMed ID: 21757934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fiducial marker implantation in prostate radiation therapy: complication rates and technique.
    Fawaz ZS; Yassa M; Nguyen DH; Vavassis P
    Cancer Radiother; 2014 Dec; 18(8):736-9. PubMed ID: 25451675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer.
    van Dorsten FA; van der Graaf M; Engelbrecht MR; van Leenders GJ; Verhofstad A; Rijpkema M; de la Rosette JJ; Barentsz JO; Heerschap A
    J Magn Reson Imaging; 2004 Aug; 20(2):279-87. PubMed ID: 15269954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathologic characterization of human prostate tissue with proton MR spectroscopy.
    Swindle P; McCredie S; Russell P; Himmelreich U; Khadra M; Lean C; Mountford C
    Radiology; 2003 Jul; 228(1):144-51. PubMed ID: 12832578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
    Créhange G; Parfait S; Liegard M; Maingon P; Ben Salem D; Cochet A; Funes de la Vega M; Cormier L; Bonnetain F; Mirjolet C; Brunotte F; Walker PM
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1087-94. PubMed ID: 20615624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MR spectroscopy of the human prostate using surface coil at 3 T: metabolite ratios, age-dependent effects, and diagnostic possibilities.
    Weis J; Jorulf H; Bergman A; Ortiz-Nieto F; Häggman M; Ahlström H
    J Magn Reson Imaging; 2011 Dec; 34(6):1277-84. PubMed ID: 21954046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined MRI and MRS in prostate cancer: improvement of spectral quality by susceptibility matching.
    Scheidler J; Vogel M; Gross P; Heuck A
    Rofo; 2009 Jun; 181(6):531-5. PubMed ID: 19353482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of magnetic resonance spectroscopy (MSR) and dynamic contrast-enhanced magnetic resonance (DCEMR) imaging for the characterization of high-grade prostatic intraepithelial neoplasia (HGPIN) foci.
    Sciarra A; Panebianco V; Salciccia S; Gentilucci A; Alfarone A; Dimare L; Lisi D; Catturino S; Di Pierro G; Von Heland M; Ciccariello M; Passariello R; Gentile V
    Urol Oncol; 2011; 29(6):634-40. PubMed ID: 19914107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Fayed N; Morales H; Modrego PJ; Pina MA
    Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiating platinum coated brachytherapy seeds and gold fiducial markers with varying off-resonant frequency offsets.
    McNabb E; Wong R; Noseworthy MD
    Magn Reson Imaging; 2019 Jul; 60():68-75. PubMed ID: 30959177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer detection: magnetic resonance (MR) spectroscopic imaging.
    Vilanova JC; Barceló J
    Abdom Imaging; 2007; 32(2):253-61. PubMed ID: 17476554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative (1) H MR spectroscopic imaging of the prostate gland using LCModel and a dedicated basis-set: correlation with histologic findings.
    García-Martín ML; Adrados M; Ortega MP; Fernández González I; López-Larrubia P; Viaño J; García-Segura JM
    Magn Reson Med; 2011 Feb; 65(2):329-39. PubMed ID: 20939087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer.
    Pickett B; Kurhanewicz J; Coakley F; Shinohara K; Fein B; Roach M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1047-55. PubMed ID: 15519774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year.
    Crehange G; Maingon P; Gauthier M; Parfait S; Cochet A; Mirjolet C; Bonnetain F; Cormier L; Brunotte F; Walker P
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e407-13. PubMed ID: 21605949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.